Tissue Sealants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

1.1 List of Tables
1.2 List of Figures

2.1 Tissue Sealants Overview

3.1 Tissue Sealants - Pipeline Products by Stage of Development
3.2 Tissue Sealants - Pipeline Products by Segment
3.3 Tissue Sealants - Pipeline Products by Territory
3.4 Tissue Sealants - Pipeline Products by Regulatory Path
3.5 Tissue Sealants - Pipeline Products by Estimated Approval Date
3.6 Tissue Sealants - Ongoing Clinical Trials

4.1 Tissue Sealants Companies - Pipeline Products by Stage of Development
4.2 Tissue Sealants - Pipeline Products by Stage of Development

5.1 Adhesys Medical GmbH Company Overview
5.2 Advanced Medical Solutions Group plc Company Overview
5.3 Aleo BME Inc Company Overview
5.4 Angiotech Pharmaceuticals Inc Company Overview
5.5 Arch Therapeutics Inc Company Overview
5.6 Arizona State University Company Overview
5.7 Baxter International Inc Company Overview
5.8 Biomedica Management Corp Company Overview
5.9 Boston University Company Overview
5.10 Calmare Therapeutics Inc Company Overview
5.11 Clemson University Company Overview
5.12 Cohera Medical Inc Company Overview
5.13 Covalent Medical, Inc. (Inactive) Company Overview
5.14 CR Bard Inc Company Overview
5.15 Department of Biomedical Engineering Columbia University Company Overview
5.16 DSM Biomedical BV Company Overview
5.17 Eidgenossische Materialprufungs- und Forschungsanstalt Company Overview
5.18 Elastagen Pty Ltd Company Overview
5.19 Ethicon Endo-Surgery Inc Company Overview
5.20 Gamma Diagnostics Inc Company Overview
5.21 GATT Technologies BV Company Overview
5.22 Hemostasis LLC Company Overview
5.23 HyperBranch Medical Technology Inc Company Overview
5.24 Institute of Molecular Biology of Parana Company Overview
5.25 InVivo Therapeutics Corp Company Overview
5.26 Johns Hopkins University Company Overview
5.27 Kollodis BioSciences Inc Company Overview
5.28 Kuros Biosciences AG Company Overview
5.29 Laser Tissue Welding, Inc. Company Overview
5.30 Medisse BV (Inactive) Company Overview
5.31 Meril Life Sciences Pvt Ltd Company Overview
5.32 Nurami Medical Ltd Company Overview
5.33 Pharming Group NV Company Overview
5.34 Polyganics BV Company Overview
5.35 Protein Polymer Technologies Inc (Inactive) Company Overview
5.36 Purdue University Company Overview
5.37 Samyang Biopharmaceuticals Corp Company Overview
5.38 Sea Run Holdings Inc Company Overview
5.39 Sealantis Ltd. Company Overview
5.40 Shanghai Haohai Biological Technology Co Ltd Company Overview
5.41 Surgical Sealants, Inc. Company Overview
5.42 Teijin Pharma Ltd Company Overview
5.43 Texas A&M University Company Overview
5.44 The Medicines Co Company Overview
5.45 Tissium SA Company Overview
5.46 University of Akron Company Overview

6.1 Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors
6.2 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
6.3 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
6.4 May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
6.5 May 19, 2022: ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2022 and Provides Corporate Update
6.6 May 16, 2022: Analysts Anticipate Artivion to Announce $0.09 Earnings Per Share
6.7 May 12, 2022: Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
6.8 May 11, 2022: Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company
6.9 May 10, 2022: Johnson & Johnson MedTech Adds New CFO to the Mix
6.10 May 10, 2022: Baxter to Host 2022 Investor Conference
6.11 May 02, 2022: Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference
6.12 Apr 21, 2022: Artivion Announces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results
6.13 Apr 20, 2022: Johnson & Johnson to Participate in the UBS Global Healthcare Conference
6.14 Apr 19, 2022: Johnson & Johnson Reports Q1 2022 Results
6.15 Apr 07, 2022: Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference
6.16 Mar 28, 2022: ThermoGenesis Holdings Announces Year End 2021 Financial Results and Provides Corporate Update
6.17 Mar 28, 2022: Leading medical device company to build Center for Excellence in Cellular Manufacturing in Greater Sacramento (Rancho Cordova)
6.18 Mar 15, 2022: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
6.19 Mar 09, 2022: Artivion to Host Investor & Analyst Day on March 23, 2022
6.20 Feb 22, 2022: Asahi Kasai Names Company Veteran as New President
6.21 Feb 15, 2022: Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors
6.22 Feb 10, 2022: Baxter to Present at Citi’s 2022 Virtual Healthcare Conference
6.23 Feb 09, 2022: Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference
6.24 Feb 07, 2022: Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference
6.25 Jan 27, 2022: Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference
6.26 Jan 25, 2022: Johnson & Johnson Reports Q4 and Full-Year 2021 Results
6.27 Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors
6.28 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
6.29 Dec 10, 2021: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
6.30 Dec 08, 2021: Johnson & Johnson to Participate in the 40th Annual J.P. Morgan Healthcare Conference
6.31 Nov 12, 2021: ThermoGenesis Holdings Announces Financial Results for the Third Quarter Ended September 30, 2021, and Provides Corporate Update
6.32 Nov 05, 2021: ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2021 and Provide a Corporate Strategic Update
6.33 Nov 02, 2021: Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference
6.34 Oct 13, 2021: Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference
6.35 Oct 12, 2021: Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
6.36 Oct 12, 2021: Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations
6.37 Oct 11, 2021: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference
6.38 Sep 27, 2021: Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors
6.39 Sep 22, 2021: Anthony Semedo Joins CryoLife Board of Directors
6.40 Sep 16, 2021: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
6.41 Sep 09, 2021: InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference
6.42 Aug 19, 2021: Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022
6.43 Aug 12, 2021: Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
6.44 Aug 12, 2021: ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2021, and Provides Corporate Update
6.45 Aug 09, 2021: Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference
6.46 Aug 05, 2021: ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2021 and Provide a Corporate Strategic Update
6.47 Jul 30, 2021: Grifols signs an agreement with ImmunoTek to open 21 plasma centers and further advances on its expansion plan
6.48 Jul 29, 2021: Baxter Reports Second-Quarter 2021 Results
6.49 Jul 29, 2021: Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit
6.50 Jul 29, 2021: CryoLife Reports Second Quarter 2021 Financial Results
6.51 Jul 27, 2021: Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference
6.52 Jul 21, 2021: Johnson & Johnson Reports 2021 Second-Quarter Results
6.53 Jul 15, 2021: CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results
6.54 Jul 07, 2021: Advanced Medical Solutions Group: Half year trading update
6.55 Jun 30, 2021: Asahi Kasei Announces Q1 2021 Financial Results

7.1 Methodology
7.2 About the Publisher
7.3 7.4 Disclaimer